GlassScriptPhysician profile
Russl Altabtabaee
NPI 1528633096
$2,395.94
in general payments reported to CMS, 2019-2025
17 companies · $24.98 in 2025
The $24.98 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.04 · 2022: $410 · 2023: $1,471 · 2024: $409 · 2025: $24.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,905.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $587.12 | 2021-2023 | Prophecy, Augment Injectable, Infinity Adaptis |
| Davol INC. | $280.08 | 2022-2023 | Arista Ah Flexitip |
| Aroa Biosurgery Incorporated | $260.85 | 2022-2024 | |
| Horizon Therapeutics Plc | $249.99 | 2023 | Krystexxa |
| Treace Medical Concepts, INC. | $166.45 | 2023-2024 | |
| Integra Lifesciences Corporation | $143.48 | 2022 | |
| Avita Medical Americas, LLC | $123.34 | 2024 | |
| Zimmer Biomet Holdings, INC. | $109.99 | 2023 | |
| Organogenesis INC. | $102.42 | 2023 | Puraply Antimicrobial |
| Vilex LLC | $96.82 | 2023 | |
| Kerecis Limited | $87.07 | 2022 | |
| Averitas Pharma INC. | $62.16 | 2023 | Qutenza |
| Smith+Nephew, INC. | $39.74 | 2024-2025 | Stravix Pl, Grafix Pl, Pico |
| Bioventus LLC | $29.00 | 2022 | |
| Convatec INC. | $21.91 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $19.34 | 2023 | Nuzyra |
| Heron Therapeutics, INC. | $16.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russl Altabtabaee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.